One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   North America Epigenetics Market

[ 英語タイトル ] North America Epigenetics Market- Growth, Trends, and Forecasts (2020 - 2025)


Product Code : MDHC0088786
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 80
Category : Healthcare and Pharmaceuticals
Study Area : North America
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3750 / Question Form
5 User USD4250 / Question Form
Enterprise User USD7000 / Question Form
 - Abcam PLC
- Active Motiff
- Diagenode Inc.
- F. Hoffmann-La Roche Ltd
- Illumina Inc.
- Qiagen N.V.
- Merck KGaA
- TherFisher Scientific
- Zyhmo Research Corporation

[Report Description]

The North America Epigenetics Market is expected to register a 20% of CAGR growth during the forecast period. The key contributor to the market is the growing burden of cancer and increasing investments into research and development activities.

According to the American Cancer Society, in 2020, around 1.8 million new cases will be diagnosed in the United States and about 606,520 people are expected to die due to it. Epigenetics modifications can influence the cellular responses with respect to the apoptosis, cell proliferation and senescence.

Hence, epigenetics has a very crucial role in cancer treatment and thereby it is expected to boost the market growth over the forecast period.

Key Market Trends

Cardiovascular Diseases are Expected to Show a Steady Growth in the North America Epigenetics Market

Cardiovascular diseases are expected to show steady growth in the market during the forecast period. Recent studies have shown that epigenetics has a very significant role in cardiovascular diseases. The information of epigenetics can help in determining the response of an individual towards the drug. In addition, it can also be developed to assess the risk determinants for cardiovascular diseases. Hence, it can be a diagnosis and prognosis of cardiovascular diseases. Heart diseases are one of the leading cause of death in the United States. As per the Centre for Disease Control and Prevention, one person dies in every 37 seconds in America due to cardiovascular disease.

Furthermore, the increasing investments into R&D are expected to impact positively on the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2018, around USD 79.6 billion were spent on the research and development activities. Thus, the aforementioned factors are expected to impact positively on the market in this segment.

Competitive Landscape

The key players in the North America Epigenetics market are Abcam PLC, Active Motiff, Diagenode Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., Qiagen N.V., Merck & Co. Inc., ThermoFisher Scientific and Zyhmo Research Corporation.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Cancer Diseases
4.2.2 Increasing Investments into Research and Development Activities
4.2.3 Rising Epigenetic Applications in Non-oncology Diseases
4.3 Market Restraints
4.3.1 Presence of Stringent Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.2 Reagents & Kits
5.1.3 Others
5.2 By Applications
5.2.1 Oncology
5.2.2 Autoimmune Diseases
5.2.3 Metabollic Diseases
5.2.4 CNS/Pain Diseases
5.2.5 Cardiovascular Diseases
5.2.6 Others
5.3 By Technology
5.3.1 Methylation
5.3.2 Acetylation
5.3.3 Phosphorylation
5.3.4 Others
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abcam PLC
6.1.2 Active Motiff
6.1.3 Diagenode Inc.
6.1.4 F. Hoffmann-La Roche Ltd
6.1.5 Illumina Inc.
6.1.6 Qiagen N.V.
6.1.7 Merck KGaA
6.1.8 TherFisher Scientific
6.1.9 Zyhmo Research Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+